Molecule found to boost immune cells leads to new cancer therapy target
A study has identified a molecule which boosts immune cell function and could be used in cancer therapies.
List view / Grid view
A study has identified a molecule which boosts immune cell function and could be used in cancer therapies.
Engineered T cell immunotherapy (such as chimeric antigen receptor T cell (CAR-T) and T cell receptor T cell (TCR-T) therapy), could potentially be used as a therapeutic strategy for tumour treatment.
When a heating technique called photothermal ablation was combined with the infusion of CAR T cells, it suppressed melanoma tumour growth for up to 20 days in mice...
Researchers have found a way to activate macrophages that have been forced to help cancer grow and spread around the body...
Frizzled receptors, from the GPCR family, could soon be a target to treat numerous diseases such as cancer, fibrosis and CVD...
Imaging agents developed to better monitor the growth of tumours and generate new therapies...
This In-Depth Focus explores current uses and future development in mass spectrometry imaging for bringing new drugs to market...
Scientists have synthesised a complex sugar structure that specifically binds to the tumour protein Galectin-1...